• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sierra Oncology, Inc. - Common Stock (NQ:SRRA)

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Jun 30, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 54.96 (50)
    Ask (Size) 55.00 (2)
    Prev. Close 54.99
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 24,419,349
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration
    From Sierra Oncology
    Via Business Wire

    Performance

    More News

    Read More
    6 Biotech Stocks to Buy Now Ahead of These June Catalysts
    Via InvestorPlace
    3 Biotech Stocks to Buy Before They Boom
    Via InvestorPlace
    Recap: Sierra Oncology Q1 Earnings
    Via Benzinga
    Analyst Ratings for Sierra Oncology
    Via Benzinga
    Momelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual Meeting
    From Sierra Oncology
    Via Business Wire
    Sierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual Meeting
    From Sierra Oncology
    Via Business Wire
    Sierra Oncology Reports First Quarter 2022 Results
    From Sierra Oncology
    Via Business Wire
    Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    From Sierra Oncology
    Via Business Wire
    SIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRA
    From Kuznicki Law PLLC
    Via Business Wire
    SIERRA ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sierra Oncology, Inc - SRRA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
    Via Benzinga
    Analyzing Sierra Oncology Inc's Short Interest
    Via Benzinga
    Advancements of CAR-T Cell Therapies Importance Grows While Cancer Cases Increasing
    Via FinancialNewsMedia
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Is Creatd (CRTD) Stock Up Today?
    Via InvestorPlace
    Dear KLDO Stock Fans, Mark Your Calendars for April 28
    Via InvestorPlace
    Why Is Sierra Oncology (SRRA) Stock Up Today?
    Via InvestorPlace
    Sierra Oncology Stock Is Soaring: Here's Why
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
    Via Benzinga
    Biotech Stock Sierra Soars On GSK Buyout As Halozyme Nabs Antares
    Via Investor's Business Daily
    The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
    Via Benzinga
    SRRA Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Sierra Oncology, Inc. Is Fair to Shareholders
    From Halper Sadeh LLP
    Via Business Wire

    Frequently Asked Questions

    Is Sierra Oncology, Inc. - Common Stock publicly traded?
    Yes, Sierra Oncology, Inc. - Common Stock is publicly traded.
    What exchange does Sierra Oncology, Inc. - Common Stock trade on?
    Sierra Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Sierra Oncology, Inc. - Common Stock?
    The ticker symbol for Sierra Oncology, Inc. - Common Stock is SRRA on the Nasdaq Stock Market
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.